Clinical Trials Directory

Trials / Sponsors / Trevi Therapeutics

Trevi Therapeutics

Industry · 14 registered clinical trials — 2 currently recruiting.

StatusTrialPhaseStarted
RecruitingA Food Effect Study to Evaluate the Relative Bioavailability of Nalbuphine Extended-Release Tablets (NAL ER) i
Healthy Participants
Phase 12026-02-27
RecruitingNAL ER IPF Respiratory Function and Safety Study
Idiopathic Pulmonary Fibrosis
Phase 12025-08-21
CompletedA Study of the Pharmacokinetic Interaction Between Pirfenidone, Nintedanib, and Nalbuphine Extended Release (N
Healthy Participants
Phase 12025-06-30
CompletedCough Reduction in IPF With Nalbuphine ER
Idiopathic Pulmonary Fibrosis
Phase 22024-02-06
CompletedRefractory Chronic Cough Improvement Via NAL ER (RIVER)
Refractory Chronic Cough
Phase 22023-11-30
CompletedA Study of Nalbuphine (Extended Release) ER in Idiopathic Pulmonary Fibrosis (IPF) for Treatment of Cough
Idiopathic Pulmonary Fibrosis
Phase 22019-10-29
CompletedStudy of Nalbuphine ER in Participants With Hepatic Impairment
Hepatic Impairment
Phase 12019-06-12
CompletedPRISM Study-Pruritus Relief Through Itch Scratch Modulation
Prurigo Nodularis
Phase 2 / Phase 32018-08-07
CompletedOral Abuse Potential Study of Nalbuphine
Nalbuphine, Opioid Abuse
Phase 12018-05-29
CompletedOpen Label Extension Study of Nalbuphine HCl ER in Patients With Prurigo Nodularis
Prurigo Nodularis, Nodularis Prurigo, Prurigo
Phase 2 / Phase 32015-08-15
CompletedStudy of Nalbuphine HCl ER Tablets in Patients With Prurigo Nodularis
Prurigo Nodularis, Nodularis Prurigo, Prurigo
Phase 2 / Phase 32015-03-01
CompletedOpen Label Extension Study of Nalbuphine HCl ER in Hemodialysis Patients With Uremic Pruritus
Uremic Pruritus, Pruritus
Phase 2 / Phase 32014-09-01
CompletedStudy of Nalbuphine HCl ER Tablets in Hemodialysis Patients With Uremic Pruritus
Uremic Pruritus, Pruritus
Phase 2 / Phase 32014-06-01
CompletedPhase 1 Study of Nalbuphine HCl ER Tablets in Hemodialysis Patients With Uremic Pruritus
Uremic Pruritus
Phase 12013-04-01